PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
19-Dec-2025 Von Willebrand Disease Treatment Market Worth $1.75 Billion by 2032: Industry Assessment, Regional Outlook, Competition Benchmarks - ResearchAndMarkets.com Businesswire
19-Dec-2025 Ikonisys finalized a Capital Increase and Debt Conversion of EUR 2.72 million with strategic investment from Avantgarde Srl and Alberto Previtali Businesswire
19-Dec-2025 Cell Therapy Media Market Trends and Global Forecasts to 2035: Commercial Scale to Drive Market Growth, Accounting for 75% of Total Demand by 2035 - ResearchAndMarkets.com Businesswire
19-Dec-2025 Vegetarian Softgel Capsules Market to Double by 2032, Driven by the Expansion of Vegan-Friendly Nutraceutical Product Portfolios Worldwide - ResearchAndMarkets.com Businesswire
19-Dec-2025 FOLD Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Amicus Therapeutics, Inc. is Fair to Shareholders Businesswire
19-Dec-2025 HBox Receives Strategic Growth Investment from Charlesbank Technology Opportunities Fund Businesswire
19-Dec-2025 ZOLL Launches Fifth-Generation LifeVest® WCD Businesswire
19-Dec-2025 Breyer Capital Expands Healthcare & Life Sciences Team With Appointment of Dr. Bret Bostwick as Venture Advisor Businesswire
19-Dec-2025 Beren, Through its Subsidiary Mandos, Submits New Drug Application to U.S. FDA for Adrabetadex in Infantile-Onset NPC Businesswire
19-Dec-2025 Mirum Pharmaceuticals Announces Additional Private Placement Financing With TCGX Businesswire
19-Dec-2025 Nimbus Therapeutics Announces Completion of Dose Escalation in Phase 1/2 Clinical Trial of NDI-219216, Novel WRN Inhibitor for MSI-H Tumors Businesswire
19-Dec-2025 EDX Medical launches new advanced bowel cancer testing service launch in the UK to improve early detection EDX Medical
19-Dec-2025 2 Day Virtual MBA Strategic Thinking for Pharma and Biopharma Professionals Training Course (Feb 23rd - Feb 24th, 2026) - ResearchAndMarkets.com Businesswire
19-Dec-2025 European Commission approves TREMFYA® (guselkumab) for the treatment of children with plaque psoriasis, marking the first paediatric indication for an IL-23 inhibitor Johnson & Johnson Innovative Medicine
19-Dec-2025 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
19-Dec-2025 Patients Searching "Best Plastic Surgeon in America" Are Traveling for Clarity and Planning - Gruber Plastic Surgery Expands Out-of-Town Resources for 2026 ACCESS Newswire
19-Dec-2025 Dr. Kunaal Jindal Sheds Light on His Signature Mommy Makeover, Which Includes his High Definition Tummy Tuck with Liposculpting and Breast Reshaping ACCESS Newswire
19-Dec-2025 Glidewell Introduces Simply Natural(TM) 3D Flexible Partials ACCESS Newswire
19-Dec-2025 Allied OMS Enters New Jersey with Partnership with Oral & Maxillofacial Surgery of Central New Jersey ACCESS Newswire
19-Dec-2025 Medical Care Technologies (OTC PINK:MDCE) Advances First AI-Powered Mobile Application Toward Launch on Google Play and Apple App Store ACCESS Newswire